(PACB) Pacific Biosciences complete technical analysis [charts+indicators] | Buy/Sell Pacific Biosciences | (PACB) share price targets
Complete technical analysis of Pacific Biosciences (PACB) by charts plus indicators, forecast predictions and share price targets for Pacific Biosciences (PACB)
Pacific Biosciences trades in USA in Capital Goods sector.
Showing technical analysis as on 2024-11-25 View latest technical analysis
10 day averaged volume of Pacific Biosciences is 12502240
| Date | Daily Closing Price | Open | High | Low | Volume |
| 25 Mon Nov 2024 | 1.85 | 1.87 | 1.96 | 1.84 | 0.691 times |
| 22 Fri Nov 2024 | 1.80 | 1.77 | 1.89 | 1.70 | 0.698 times |
| 21 Thu Nov 2024 | 1.77 | 1.74 | 1.84 | 1.70 | 0.644 times |
| 20 Wed Nov 2024 | 1.72 | 1.75 | 1.78 | 1.65 | 0.671 times |
| 19 Tue Nov 2024 | 1.72 | 1.55 | 1.75 | 1.49 | 0.943 times |
| 18 Mon Nov 2024 | 1.57 | 1.69 | 1.69 | 1.57 | 1.062 times |
| 15 Fri Nov 2024 | 1.60 | 1.88 | 1.88 | 1.56 | 1.82 times |
| 14 Thu Nov 2024 | 1.86 | 2.01 | 2.03 | 1.85 | 1.01 times |
| 13 Wed Nov 2024 | 1.98 | 2.26 | 2.30 | 1.98 | 0.818 times |
| 12 Tue Nov 2024 | 2.21 | 2.44 | 2.66 | 2.18 | 1.113 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 1.8 as stoploss in an intra day buy trade for a target of 2.09. However, stock will show a bearish move below 1.8.
Share price targets for Pacific Biosciences (PACB)
| Target Type | Value |
| Downside Target | 1.16 |
| Downside Target | 1.27 |
| Downside Target | 1.33 |
| Downside Target | 1.42 |
| Downside Target | 1.49 |
| Downside Target | 1.56 |
| Downside Target | 1.78 |
| Downside Target | 1.82 |
| Upside Target | 1.89 |
| Upside Target | 1.96 |
| Upside Target | 2.10 |
| Upside Target | 2.26 |
| Upside Target | 2.40 |
| Upside Target | 2.50 |
| Upside Target | 2.66 |
| Upside Target | 2.72 |
Intraday share price targets for Pacific Biosciences (PACB)
| Target Type | Value |
| Downside Intraday Target | 1.81 |
| Downside Intraday Target | 1.76 |
| Upside Intraday Target | 1.93 |
| Upside Intraday Target | 2 |
| Upside Intraday Target | 1.88 |
Weekly technical analysis of Pacific Biosciences (PACB)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 25 Mon Nov 2024 | 1.85 | 1.87 | 1.96 | 1.84 | 0.172 times |
| 22 Fri Nov 2024 | 1.80 | 1.69 | 1.89 | 1.49 | 0.672 times |
| 15 Fri Nov 2024 | 1.60 | 2.34 | 2.66 | 1.56 | 0.891 times |
| 08 Fri Nov 2024 | 2.30 | 2.45 | 2.72 | 1.82 | 1.779 times |
| 01 Fri Nov 2024 | 2.44 | 1.80 | 2.50 | 1.78 | 2.195 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Pacific Biosciences (PACB)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 25 Mon Nov 2024 | 1.85 | 2.21 | 2.72 | 1.49 | 1.334 times |
| 31 Thu Oct 2024 | 2.17 | 1.68 | 2.40 | 1.42 | 0.919 times |
| 30 Mon Sep 2024 | 1.70 | 1.36 | 2.14 | 1.27 | 1.087 times |
| 30 Fri Aug 2024 | 1.37 | 2.06 | 2.10 | 1.33 | 0.725 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Pacific Biosciences (PACB)
Price action analysis of Pacific Biosciences ( (PACB) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Pacific Biosciences ( (PACB) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Pacific Biosciences ( (PACB) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Pacific Biosciences ( (PACB) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Pacific Biosciences stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Pacific Biosciences in short term and the sell signal is strong.
Pacific Biosciences Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Pacific Biosciences in short term and BUY signal is strong.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Pacific Biosciences is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.79 and Pacific Biosciences (PACB) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Pacific Biosciences (PACB) stock. Volume based technical analysis of Pacific Biosciences (PACB) stock is negative.
Pacific Biosciences Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Pacific Biosciences ( (PACB) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Pacific Biosciences ( (PACB) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Pacific Biosciences ( (PACB) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Pacific Biosciences ( (PACB) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Pacific Biosciences stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Pacific Biosciences in short term and the sell signal is strong.
Pacific Biosciences Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Pacific Biosciences in short term and BUY signal is strong.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Pacific Biosciences is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.79 and Pacific Biosciences (PACB) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Pacific Biosciences (PACB) stock. Volume based technical analysis of Pacific Biosciences (PACB) stock is negative.
Pacific Biosciences Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.